ATTRPod Podcast Evaluation

Course Title for Certificate
Name*

First NameLast Name
Email*
example@example.com
What best describes your title?*

MDRN/NPPAPharmDProfessorIndustryOther
How many years have you been in practice?
1. Which of the following laboratory tests are recommended in screening for AL amyloidosis?*

a. Serum and urine electrophoresisb. Serum free light chains and immunofixation of the serum and urinec. B2 microglobulind. NT pro BNP and troponin Te. CBC with differential
2. The most common hereditary transthyretin variant in the United States is:*

a. T60A (p.Thr80Ala) and found in patients of Irish ancestryb. V30M (p.Val50Met) found in patients of Portuguese descentc. V122I (p.Val142Ile) found mainly in African American patientsd. S77T (p.Ser97Tyr) found in patients of German descente. None of the above
3. Which of the following is approved for the treatment of transthyretin amyloid cardiomyopathy in the United States?*

a. Diflunisalb. Vutrisiranc. Patisirand. Green tea extracte. Inotersen
4. Which of the below treatments increases serum transthyretin levels?*

a. Acoramidisb. Eplontersenc. Vutrisirand. Iontersene. Patisiran
How many patients do you currently see each month regarding transthyretin amyloidosis?

Less than 55-1516-2526 or moreN/A

Learning Objectives

Rows	Poor	Fair	Good	Very Good	Excellent
Review the genetics and pathogenesis of ATTR-CM, as well as existing treatment guidelines (US and European) and how those factors inform approaches to patient identification and recognition of heart failure risk
Analyze clinical trial data presented at ACC2025 for the treatment of patients with ATTR-CM
Evaluate practical strategies to incorporate new data into current and future practice in the management of individuals with ATTR-CM

Please provide us with feedback regarding your experience at the activity:

Do you feel this activity was fair, balanced, and free of commercial bias?

YesNo
If no, please explain:
This educational activity will result in a change in my role as a healthcare team member.

YesNoN/A
Based on your participation in this activity, choose the statement(s) that applies to how your role as a healthcare team member will change:

I gained new strategies/skills/information that my team can apply to practiceI plan to implement new strategies/skills/information in my practiceI will be more competent in my team’s management of patient careI will improve my communication with the healthcare team
What factors beyond clinical care that effect the health of your patients does your team experience?
Attestation:

AcademicCME designates this enduring material for a maximum of 1.0 AMA PRA Category 1 Credits^TM.
Date

MonthDayYear
Date
Credits
Should be Empty: